Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinorelbine Versus Gemcitabine and Carboplatin in Elderly Advanced NSCLC
NCT00265694Phase 3Unknown
- Sponsor
- Inje University
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of vinorelbine, gemcitabine, carboplatin in non-small cell lung cancer (NSCLC), sponsored by Inje University. Status: unknown.
02
Drugs
vinorelbinegemcitabinecarboplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00265694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00265694.